AbCellera Biologics Inc.
Disclosed SEC business address
150 W 4TH AVENUE, VANCOUVER, A1, V5Y 1G6
AbCellera Biologics Inc. (ticker ABCL, CIK 0001703057) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: British Columbia, Canada. Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 5 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-19T08:39:26.912278+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:19:08.911974+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:19:12.880036+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:19:19.372416+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.